Like any drug, GLP-1s carry risks
If you take them with ginkgo biloba or garlic supplements, they can affect blood clotting and increase the risk of bleeding
Patients should seek medical evaluation for severe pain after injury, inability to bear weight, major swelling, deformity, numbness, weakness, fever, signs of infection, worsening abdominal pain, blood in stool, persistent vomiting, chest pain, shortness of breath, or neurological symptoms
Gentle exercise is preferable during recovery from noninvasive treatments
When reporting eCQMs under the REHQR Program, REHs must adhere to the following requirements: (1) REHs must utilize technology certified to the Office of the National Coordinator for Health Information Technology's (ONC's) health information technology (IT) certification criteria, as adopted and updated in 45 CFR 170.315, for reporting eCQMs under the REHQR Program
In the United States, the FDA regulates drugs for human use, but vendors selling compounds labelled for research purposes only operate in a grey zone that makes straightforward enforcement difficult
